Centers for Disease Control and Prevention: Accelerating Epidemic Control in Uganda under PEPFAR

Deadline: 18 October 2016

The Centers for Disease Control and Prevention (CDC), an agency of Department of Health and Human Services (DHHS) is seeking applications from eligible organizations for a program entitled “Accelerating Epidemic Control in Mubende Region in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR)”.

Goals

Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission;
Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for inter-current diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART);
Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety;
Developing, validating and/or evaluating public health programs to inform, improve and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB and opportunistic infections.

Funding Information

Approximate Total Fiscal Year Funding: $14,086,013
Total Project Period Length: 5 year(s)

Focus Activities

Implement a woman- and girl-centered approach;
Increase impact through strategic coordination and integration;
Strengthen and leverage key multilateral organizations, global health partnerships and private sector engagement;
Encourage country ownership and invest in country-led plans;
Build sustainability through investments in health systems;
Improve metrics, monitoring and evaluation;
Promote research, development and innovation

Expected Outcomes

Short term Outcomes (1-2 years)
- Increased yield of newly identified HIV+
- Improved and timely linkage of HIV+ adults and children to HIV care and ART treatment services
- Increased coverage of PLHIV current on ART who receive a viral load test
- Improved ICF and TB treatment among TB/HIV patients
- Increased facilities with satisfactory PT performance
- Improved sample transportation and results transmission
- Increased coverage of HIV prevention services, including VMMC among targeted age group
- Increased linkage of OVC to core services
- Increased linkage of OVC to core services
- Improved data quality
- Increased competencies of DHTs in scale up districts to review, analyze, and use HIV program data
Intermediate Outcomes (3-4 years)
- Increased ART coverage, adherence, and retention of PLHIV
- Increased PLHIV who are virally suppressed
- Reduced HIV transmission (including MTCT)
- Improved TB treatment rates for TB/HIV clients
- Increased labs achieving minimum standard towards accreditation
- Increased access to quality laboratory services
- Increased proportion of OVC graduated from the core services
- Reduced high-risk behaviors among PLHIV and VMMC clients
- Increased oversight of HIV programs in districts
- Improved data use for programming and client care
Long-term Outcomes (5+ years)
- Reduced HIV incidence
- Reduced HIV and TB related mortality
- Increased ability of regions to plan, coordinate, and monitor the HIV epidemic